Compass Therapeutics CMPX
NASDAQ CMPX
$1.10 -0.01 (-1.36%)
As of: Sep 29, 2026 · 3:59 PM EDT

Compass Therapeutics (CMPX) Common Equity (2018 - 2026)

Updated

Compass Therapeutics (CMPX) posted Common Equity of $166.05 million for Q2 2026, up 78.2% from $93.21 million a year earlier but down 11.0% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Common Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Compass Therapeutics' Common Equity came in at $196.79 million, up 57.1% from FY2024.

  • Annual Common Equity shows a five-year compound annual growth rate of 37.6% (FY2020 to FY2025).
  • In prior years, Compass Therapeutics' Common Equity was $125.23 million in FY2024 (-15.7%), $148.54 million in FY2023 (-18.2%), $181.64 million in FY2022 (+29.7%) and $140.08 million in FY2021 (+250.7%).
  • Quarterly Common Equity has run from a low of $23.89 million in Q3 2021 to a high of $209.61 million in Q3 2025 over five years.
  • On a year-over-year basis, Common Equity has increased in each of the last four quarters, with growth averaging 20.1% over the last eight quarters.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q3 2022, with growth of 386.1%; the weakest was Q2 2025, with a decline of 36.2%.
  • According to Business Quant data, Common Equity for the three prior quarters was $186.47 million (Q1 2026), $196.79 million (Q4 2025) and $209.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Compass Therapeutics 199.90 Mn 199.90 Mn - 166.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 166.05 Mn
Mar 31, 2026 186.47 Mn
Dec 31, 2025 196.79 Mn
Sep 30, 2025 209.61 Mn
Jun 30, 2025 93.21 Mn
Mar 31, 2025 110.28 Mn
Dec 31, 2024 125.23 Mn
Sep 30, 2024 138.40 Mn
Jun 30, 2024 146.10 Mn
Mar 31, 2024 157.06 Mn
Dec 31, 2023 148.54 Mn
Sep 30, 2023 160.05 Mn
Jun 30, 2023 168.29 Mn
Mar 31, 2023 175.27 Mn
Dec 31, 2022 181.64 Mn
Sep 30, 2022 116.12 Mn
Jun 30, 2022 126.93 Mn
Mar 31, 2022 134.49 Mn
Dec 31, 2021 140.08 Mn
Sep 30, 2021 23.89 Mn
API Access

Compass Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CMPX&period=max&api_key=YOUR_API_KEY